Displaying results 1-10 of 1142 for "WA 0859 3970 0884 Harga Interior Rumah Hook 2 Lantai WIlayah Pakem Sleman"

• ASBMB Today Article
  SARS-CoV-2 variants remodel cellular landscapes
  Oct. 19, 2023
  

  Scientists find that the ancestral strain of SARS-CoV-2 and the omicron and delta variants trigger varying immunological responses.
• Meetings and events
  Insight on novel roles and regulation of phosphoinositide lipids
  

  Dec. 2, 2020
• ASBMB Today Article
  A great escape — how SARS-CoV-2 evades our defenses
  May 25, 2023
  

  Preliminary evidence shows that SARS-CoV-2 uses molecular mimicry, in which one of its proteins acts like a protein in our immune system.
• ASBMB Today Article
  Annual meeting workshops: Part 2
  Jan. 21, 2020
  

  Topics include lab management, moving from academia to industry, and teaching biology with augmented reality and Lego bricks.
• Meetings and events
  Lipids in viral infection: part 2
  

  Oct. 14, 2020
• ASBMB Today Article
  Essential process for SARS-CoV-2 viral replication visualized
  July 2, 2023
  

  High-resolution images provide clarity into how viral proteins are separated by a protease, an important step during virus replication that is targeted by an approved COVID-19 drug.
• Meetings and events
  Addressing imposter fears at any career stage
  

  Sept. 24 | 2 p.m. EDT
• ASBMB Today Article
  Acylcarnitines, a warning signal for Type 2 diabetes
  March 15, 2022
  

  One of the lipid classes elevated in plasma with diabetic dyslipidemia, acylcarnitines function in transport and signaling.
• ASBMB Today Article
  A small army of researchers races
  to build a coronavirus interactome
  April 1, 2020
  

  Led by a professor at UCSF, scientists at eight institutions in the U.S. and Europe have used a protein interaction map to identify 69 drugs that might work against SARS-CoV-2, the virus that causes COVID-19.
• ASBMB Today Article
  Pointers for an industry career: part 2
  Sept. 1, 2016
  

  This is the second in a three-part series of interviews with Kenneth I. Maynard of Takeda Pharmaceuticals International Inc. about what it takes to launch a career in industry.